More about
Fc Receptor
News
June 25, 2024
3 min read
Save
‘Proof of concept’ established for FcRn receptor blocker nipocalimab in Sjogren’s disease
Patients with Sjögren’s disease treated with nipocalimab, a novel neonatal Fc receptor blocker, demonstrate significant improvement vs. those who receive placebo at week 24, according to data presented at the EULAR 2024 Congress.
News
December 22, 2023
2 min read
Save
The next generation of rheum agents: Immunomodulation with neonatal Fc receptor targeting?
Our cover story this month is on the next wave of immune-based therapies for patients with immune-mediated inflammatory conditions — and the prospects are bright.